Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRC-OA for Pain Treatment in Osteoarthritis of the Knee
NCT06828666Phase 2Completed
- Sponsor
- Britecyte, Inc.
- Start
- May 2025
- Primary completion
- Feb 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of BRC-OA in osteoarthritis (OA), sponsored by Britecyte, Inc.. Started May 2025; status: completed.
02
Drugs
BRC-OA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06828666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06828666.